Related Experiment Video
Updated: Sep 30, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
[Pulmonary hypertension. Defining the structure and the departmental function based on risk]
1Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Departamento de Hipertensión Pulmonar y Corazón Derecho. Ciudad de México, México.
This study proposes a specialized departmental model for comprehensive pulmonary hypertension patient care. It outlines current knowledge on pulmonary hypertension, mortality, prognosis, and severity stratification to support this model.
Area of Science:
- Cardiology
- Pulmonology
- Healthcare Management
Background:
- Pulmonary hypertension (PH) is a severe condition with significant mortality and variable prognosis.
- Accurate stratification of PH severity is crucial for effective patient management and treatment planning.
- Existing care models may not adequately address the complex, multidisciplinary needs of PH patients.
Purpose of the Study:
- To present a novel departmental model for the comprehensive care of patients with pulmonary hypertension.
- To consolidate current knowledge regarding PH, including its epidemiology, clinical outcomes, and prognostic factors.
- To provide a framework for organizing specialized PH services based on disease severity.
Main Methods:
- Review and synthesis of current medical literature on pulmonary hypertension.
- Analysis of data on PH mortality, prognosis, and established severity stratification criteria.
- Conceptualization and description of a proposed departmental structure and its functions.
Main Results:
- The proposed model integrates specialized expertise for improved pulmonary hypertension management.
- Summarizes key aspects of PH knowledge, including risk factors and progression.
- Highlights the importance of severity-based stratification for resource allocation and treatment intensity.
Conclusions:
- A dedicated departmental approach can enhance the comprehensive care of pulmonary hypertension patients.
- The proposed model provides a structured framework for multidisciplinary PH management.
- Evidence supports the need for specialized centers to address the complexities of pulmonary hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism I: Introduction
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pathophysiology of Heart Failure
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

